Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection. (2nd January 2019)

• Record Type: Journal Article
• Authors: Nichols, Madeleine J.; Gates, Thomas M.; Soares, James R.; Moffat, Kirsten J.; Rae, Caroline D.; Brew, Bruce J.; Cysique, Lucette A.
• Is Part Of: AIDS. Volume 33:Number 1(2019)
• Publication Date: 2019-01-02
• Subjects: brain atrophy -- cognition -- HIV -- HIV-associated neurocognitive disorder -- neuroimaging -- viral suppression -- volumetric MRI; AIDS (Disease) -- Periodicals; Acquired Immunodeficiency Syndrome; AIDS (Disease); Periodicals; Periodicals; 616.9792005
• DOI: 10.1097/QAD.0000000000002042
• Languages: English
• ISSNs: 0269-9370

Abstract

Abstract : Objective: There is a lack of evidence for the neurobiological underpinning of asymptomatic neurocognitive impairment (ANI) and mild neurocognitive disorders (MNDs) in virally suppressed HIV-positive persons. We hypothesized that such mild impairment would be associated with focal brain atrophy. Design: A cross-sectional observational study. Methods: Eighty-five virally suppressed HIV-positive and 44 geographically, demographically and lifestyle comparable HIV-negative men underwent anatomical MRI, neuropsychological evaluation and HIV laboratory tests. Volumes of interest (VOI) from magnetic resonance (MR) images were extracted using FreeSurfer to yield grey and white matter volumes in regions associated with HIV-related brain injury. HIV-associated neurocognitive disorder (HAND) [ANI = 38%, MND = 13%, HIV-associated dementia (HAD) = 3% vs. neuropsychologically-normal] was classified using Global Deficit Score (GDS ≥0.5) and functional decline. Effects of HIV status on VOI were assessed with multivariate analyses controlling for family-wise error. HAND categories and HIV biomarker effects on VOI were assessed with multiple regression. Results: Relative to the HIV-negative group, the HIV-positive group demonstrated subcortical grey ( d = 0.50–0.60) and white matter (d = 0.43–0.69) atrophy, with relative cortical sparing ( d = 0.23). ANI showed reduced medial-orbitofrontal white matter compared with NP-normal cases ( P = 0.04). MND showed enlarged lateral ventricles ( P = 0.02) and reduced caudal-middle-frontal white matter ( P = 0.04), caudal-anterior-cingulate white matter ( P = 0.006) and inferior-parietal white matter ( P = 0.04) compared with neuropsychologically normal. Across the HIV-positive group, lower CD4 + /CD8 ratio was the strongest predictor of atrophy in subcortical regions. Across HAND categories, HIV disease duration uniquely predicted greater medial-orbitofrontal white matter atrophy only in ANI ( P = 0.002). Conclusion: ANI shows specific frontal white matter atrophy to which HIV disease duration is a unique contributor. MND is characterized by more widespread subcortical atrophy. Abstract : Supplemental Digital Content is available in the text